Shield Therapeutics (STX.L) traded flat 0 % during a 24 hours period ending at 10:09 AM Central Europe on Tuesday 27th. One Shield Therapeutics stock can currently be bought for about GBX 5.3 on popular exchanges. Current supply of Shield Therapeutics stocks is 10.7 mn. Shield Therapeutics has a current market capitalization of GBX 77.3 mn and approximately GBX 3.9 mn worth of Shield Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Shield Therapeutics has traded 0.73 % up. Simple moving average of last 200 days is at GBX 7.12. The highest price of past 52 weeks was recorded at GBX 12.5 on 01/16/2026. 52 weeks low was at GBX 3.7 on 08/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Topps Tiles (TPT.L) traded up 0.57 % and now trades at GBX 35.9. Topps Tiles has a market capitalisation of GBX 92.3 mn. Topps Tiles has a current price to earnings ratio of 13.84.

  • Octopus Aim Vct (OSEC.L) traded flat 0 % and now trades at GBX 30.4. Current market capitalisation for Octopus Aim Vct is GBX 90 mn. Octopus Aim Vct has a current price to earnings ratio of 28.95.

  • Eco Animal Health (EAH.L) traded flat 0 % and now trades at GBX 95.5. Eco Animal Health has a market capitalisation of GBX 85.2 mn. Current price/earnings ratio for Eco Animal Health is 29.84.

  • Triad (TRD.L) traded flat 0 % and now trades at GBX 385. Current market capitalisation for Triad is GBX 91 mn. Triad has a current price to earnings ratio of 39.47.

  • Kooth (KOO.L) traded up 3.84 % and now trades at GBX 188.5. Current market capitalisation for Kooth is GBX 88.6 mn. Current price/earnings ratio for Kooth is 11.32.

About Shield Therapeutics

Shield Therapeutics PLC is a specialty pharmaceutical company from the United Kingdom, which has its main base in Gateshead. The company’s sector of operation is Health Care and its primary industry is Pharmaceuticals. Their mission revolves around the development and commercialization of secondary care-focused pharmaceuticals. The key late-stage products of Shield Therapeutics include an innovative oral medication for the treatment of iron deficiency anemia and an iron-based phosphate binder for addressing hyperphosphatemia issues. You can find more information about this company and its offerings on their official website, which is www.shieldtherapeutics.com . They are listed on the London Stock Exchange.